Investor profile
Novo A has backed 5 European tech companies across 9 funding rounds between 2004 and 2016, joining rounds totalling €470M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Symphogen | Denmark | 5 | €249M |
| Adaptimmune | UK | 1 | €79M |
| Merus | Netherlands | 1 | €73M |
| F2G | UK | 1 | €55M |
| NeRRe Therapeutics | UK |
| 1 |
| €14M |
| €68M |
| 2015-10 |
| F2G | Growth/Late | €55M | 2016-06 |
| Symphogen | Growth/Late | €41M | 2013-05 |
| Symphogen | Series D+ | €21M | 2006-01 |
| Symphogen | Series C | €20M | 2004-11 |
| NeRRe Therapeutics | Series A | €14M | 2012-12 |
